Seroprevalence of Hepatitis B and C Infections Among HIV/AIDS Patients Attending Aminu Kano Teaching Hospital, Kano State, Nigeria

Authors

  • Edia-Asuke, U.A. Department of Microbiology, Ahmadu Bello University Zaria, Kaduna State, Nigeria.
  • Usman, H.S. Department of Microbiology, Ahmadu Bello University Zaria, Kaduna State, Nigeria.

DOI:

https://doi.org/10.47430/ujmr.1721.029

Keywords:

HBV, Liver Infection, Immunodeficiency, HCV, Kano

Abstract

This study was carried out to determine the prevalence of hepatitis B and C infections among HIV/AIDS patients attending Aminu Kano Teaching Hospital, Kano, Nigeria. A hundred and fifty HIV patients attending the HIV Clinic at the hospital were screened for hepatitis B surface antigens (HBsAg) and anti HCV. Twenty four out of the one hundred and fifty patients tested positive to hepatitis, giving an overall prevalence of 16%. There was no record of Hepatitis B and C co-infection among the HIV patients, however, 19(12.67%) and 5(3.33%) of the patients tested positive to hepatitis B and C respectively. Hepatitis B was more prevalent than hepatitis C, and the limited knowledge about hepatitis among the respondents, was a predisposing risk factor (p= 0.001) to the infection. HIV- hepatitis co-infection increases the risk of life threatening complications and may also complicate HIV treatment and management. As a result, it is important to routinely screen HIV patients for hepatitis B and C in order to improve quality of life through early detection and proper treatment/management using appropriate drug regimens.

Downloads

Download data is not yet available.

References

Abdelwahab, K.S and Said, Z.N.A. (2016). Status of Hepatitis C virus vaccination; Recent update. World Journal of Gastroenterology, 22(2): 860-873.

https://doi.org/10.3748/wjg.v22.i2.862

Adesina O., Oladokun A., Akinyemi O., Adedokun B., Awolude O., Odaibo G, et al. (2010). Human immune-deficiency virus and hepatitis B virus coinfection Hospital, Ibadan. African Journal of Medical Science,39(4): 305-310.

Bala, J.A., Kawo, A.H., Mukhtar, M.D., Sarki, A., Magaji, N., Aliyu, I.A. and Sani,M.N. (2012). Prevalence of hepatitis C virus infection among blood donors in some selected hospitals in Kano, Nigeria. InternationalResearchJournal of Microbiology.3 (6): 217-222.

Ballah A.D., Babajide A., Abubakar U.A., Abubakar A.B., Cecilia A., Ernest E. and Mohammed B.A. (2011). A survey of hepatitis B and C viruses' prevalence in HIV positive patients in tertiary institution in North-Eastern Nigeria.International Journal of Medical Science.4(1): 13-18.

https://doi.org/10.5897/IJMMS11.121

Baseke J., Musenero M. and Mayanja-Kizza H. (2015). Prevalence of hepatitis B and C in relation to liver damage in HIV infected patients attending Joint Clinical Research centre Clinic (JCRC), Kampala Uganda.AfricanHealthScience. 15(2):232.

https://doi.org/10.4314/ahs.v15i2.3

Bonacini M., Lorie S. and Bzowej N.(2004). Survival in patients with HIV infection and viral hepatitis B and C: A cohort Study. Aids.18(15):2039-2045

https://doi.org/10.1097/00002030-200410210-00008

Centre for Disease Control (CDC) (2014). HIV and viral hepatitis.National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Division of HIV/AIDS Prevention.Library Factwww.cdc.gov.Accessed on 4/11/2017.

CheesbroughM.(2006). District laboratory practice in tropical countries.Part 1.CambrigeUniversity Press. Pp. 67-69.

https://doi.org/10.1017/CBO9780511543470

Chen T.Y., Ding E.L., Seage Iii G.R. and KimA.Y. (2009). Meta-analysis: increased mortality associatedwith hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clinical Infectious Diseases, 49(10): 1605-1615.

https://doi.org/10.1086/644771

Chmielewska, A.M., Naddeo, M., Capone, S., Ammendola, V., Hu, K., Meredith, I., Verhoye, I., Rychlowski, M., Rappuoli, R., Ulmer, J.B. (2014). Combined Adenovirus vector and hepatitis C virus enveloped protein prime- boost regimen elicits T cell and neutralizing antibody immune responses. Virology, 5502-5510.

https://doi.org/10.1128/JVI.03574-13

Daw, M.A., El Bouzedi, A., and Libya Study Group of Hepatitis and HIV. (2014). Prevalence of hepatitis B and hepatitis C infections in Libya: Results from a national population based survey. BMCInfectiousDiseases, 14: 17

https://doi.org/10.1186/1471-2334-14-17

Drosten C., Nippraschk T., Manegold C., Meisle H., Brixner V., Roth W., Apedjinou A. and Gunther S.(2004). Prevalence of hepatitis B virus DNA in anti-HBc positive /HBeAg negative sera correlates with HCV but not HIV sero- status. Journal of Clinical Virology.29:59-68.

https://doi.org/10.1016/S1386-6532(03)00090-8

Haliru, N.K., and Ajayi, O.I. (2000). Risk factors and seroprevalence of hepatitisantibody in blooddonors in Nigeria. East African Medical Journal 77:410-412.

Hamza M., Samaila A.A., Yakasai A.M., Babanshani M., Borodo M.M. and HabibA.G. (2013). Prevalence of hepatitis B and C viruses infections among HIV- infected patients in tertiary hospitals in North-Western Nigeria. Nigerian Journal of Basic Science.10: 76-81.

https://doi.org/10.4103/0331-8540.122765

Idoko J., Meloni S., Muazu M., Nimzing L., Badung B. Hawkins C., et al. (2009). Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. ClinicalInfectiousDiseases, 49(8):1268-1273.

https://doi.org/10.1086/605675

OdusanyaO.O. (2008).Hepatitis B virus vaccine- the Nigerian story.IFEMED Journal.

https://doi.org/10.4314/ifemed.v14i1.41725

Otegbayo J.A., Taiwo B.O., Akingbola T.S., Odaibo G.N., Adedapo K.S., Penugonda S., Adewole I.F., Olaleye D.O., Murphy R., and Kanki P. (2008). Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV- infected patients. Annals of Hepatology7(2): 152-156.

https://doi.org/10.1016/S1665-2681(19)31872-1

Perez C.M., Saurez E., Torres E.A., Roman K. and Colon V. (2005).Seroprevalence of HCV and associated risk behaviors: a population based study in San Jan, Puerto Rico. Journal of Viral Hepatology.34(3):593-599.

https://doi.org/10.1093/ije/dyi059

Serisena N., Njoku M., Idoko J., Isamade E., Barau C., Jelpe D., Zamani A., and OtowaS(2002).Carriage rate of hepatitis B surface antigen in an urban community in Jos, Plateau State, Nigeria.Nigerian Postgraduate Medical Journal.9: 7-10

https://doi.org/10.4103/1117-1936.171015

Thio C.L. (2003). Hepatitis B in HIV infected patients: Epidemiology, natural history andtreatment. Seminar on Liver Diseases.23:125-136.THOMAS D., ASTEMBORSKI J. and RAI R.(2000). Thenatural history of HCV infection: Host, viral and environmental factors. Journal

Thomas D., Astemborski J. and Rai R.(2000). The natural history of HCV infection: Host, viral and environmental factors. Journal of American Medical Association. 284:450-456

https://doi.org/10.1001/jama.284.4.450

Tremeau-Bravard A., Ogbukagu, I.C., Ticao, C.J., and Abubakar J.J. (2012). Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. African Health Sciences, 12 (3): 312-317.

https://doi.org/10.4314/ahs.v12i3.10

Downloads

Published

30-06-2017

How to Cite

Edia-Asuke, U.A., & Usman, H.S. (2017). Seroprevalence of Hepatitis B and C Infections Among HIV/AIDS Patients Attending Aminu Kano Teaching Hospital, Kano State, Nigeria. UMYU Journal of Microbiology Research (UJMR), 2(1), 200–205. https://doi.org/10.47430/ujmr.1721.029

Issue

Vol. 2 No. 1 (2017): UMYU Journal of Microbiology Research (UJMR), Volume 2, Number 1, June 2017

Section

Articles

License

Copyright (c) 2023 UMYU Journal of Microbiology Research (UJMR)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.